Gyromitra esculenta mushroom: a comparative assessment of its carcinogenic potency.
A comparative assessment is performed on one of the false morel mushrooms, Gyromitra esculenta, including the amounts of some hydrazines present in this fungus, the cancer-inducing doses of these chemicals or the mushroom used in animal experiments, the total amounts of the hydrazines or mushroom needed to induce neoplasms in mice and the estimated total amounts of hydrazines or mushroom needed to induce cancer in humans. When one compares the estimated amounts of hydrazines required to induce cancer with the amount of raw Gyromitra esculenta needed to yield a similar effect, it becomes clear that to date 37 percent of the carcinogenic ingredients of this fungus have been identified.
Toth
B
B
Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha 68198, USA.
Gannett
P
P
D000818:Animals; D001203:Ascomycota / Q000737:chemistry*; D015197:Carcinogenicity Tests; D002273:Carcinogens / Q000032:analysis / Q000633:toxicity*; D006801:Humans; D006834:Hydrazines / Q000032:analysis / Q000633:toxicity*; D051379:Mice
D002273:Carcinogens; D006834:Hydrazines